Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (621-630 of 839) with videos related to

Pageof 84
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2015
Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growthYoshiaki Yamamoto, Yohann Loriot, Eliana Beraldi, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Comparison of Explainable AI Models for MRI-based Alzheimer's Disease ClassificationTamoghna Chattopadhyay, Neha Ann Joshy, Chirag Jagad, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2023
Cryo-EM structure determination of small therapeutic protein targets at 3 Å-resolution using a rigid imaging scaffoldRoger Castells-Graells, Kyle Meador, Mark A Arbing, et al.
Cancer Research|May 19, 2007
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancerElahe A Mostaghel, Stephanie T Page, Daniel W Lin, et al.
Nature Medicine|November 9, 2010
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistanceHiroshi Tanaka, Evelyn Kono, Chau P Tran, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB(2) agonists for the treatment of inflammatory painRobert J Gleave, Paul J Beswick, Andrew J Brown, et al.
Oncotarget|December 31, 2016
Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent mannerKevin J Tam, Kush Dalal, Michael Hsing, et al.
Genome Biology|January 28, 2016
Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patientsNada Lallous, Stanislav V Volik, Shannon Awrey, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancerShan Wang, Rahul K Kollipara, Nishi Srivastava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer BiopsiesMichael C Haffner, Michael J Morris, Chien-Kuang C Ding, et al.
Pageof 84

Showing results (621-630 of 839) with videos related to

Sort By:
Pageof 84
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2015
Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growthYoshiaki Yamamoto, Yohann Loriot, Eliana Beraldi, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Comparison of Explainable AI Models for MRI-based Alzheimer's Disease ClassificationTamoghna Chattopadhyay, Neha Ann Joshy, Chirag Jagad, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2023
Cryo-EM structure determination of small therapeutic protein targets at 3 Å-resolution using a rigid imaging scaffoldRoger Castells-Graells, Kyle Meador, Mark A Arbing, et al.
Cancer Research|May 19, 2007
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancerElahe A Mostaghel, Stephanie T Page, Daniel W Lin, et al.
Nature Medicine|November 9, 2010
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistanceHiroshi Tanaka, Evelyn Kono, Chau P Tran, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB(2) agonists for the treatment of inflammatory painRobert J Gleave, Paul J Beswick, Andrew J Brown, et al.
Oncotarget|December 31, 2016
Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent mannerKevin J Tam, Kush Dalal, Michael Hsing, et al.
Genome Biology|January 28, 2016
Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patientsNada Lallous, Stanislav V Volik, Shannon Awrey, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancerShan Wang, Rahul K Kollipara, Nishi Srivastava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer BiopsiesMichael C Haffner, Michael J Morris, Chien-Kuang C Ding, et al.
Pageof 84